Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
The extension of indication authorizes use in individuals with spinal cord injury (SCI) from levels C4 to L5 and in those with multiple sclerosis (MS), broadening access to upright, hands-free gait ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback